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Summary
Objective: To establish an immortalized normal human articular chondrocyte line which could be useful for a better understanding of cell
molecular mechanisms relevant for the development of new therapeutic approaches in rheumatic diseases.
Design: Chondrocytes from human adult articular healthy cartilage were transfected in primary culture with a plasmid containing two human
papilloma virus type 16 (HPV-16) early function genes: E6 and E7, using the highly efficient cationic liposome-mediated (lipofection)
procedure. The transfection was verified by reverse transcriptase-polymerase chain reaction analysis of E7 mRNA and by immunofluorence
localization of the E7 protein in the cell cytoplasm. The established chondrocyte cell line was examined in monolayer and in two culture
conditions that were described to re-induce differentiated characteristics: culturing in a serum-free defined medium supplemented with an
insulin-containing serum substitute and seeding on a hyaluronan-based non-woven structured biomaterial. The expression of markers
characteristic of cartilage was shown in the mRNA by reverse transcriptase-polymerase chain reaction. Immunohistological staining and
Western blotting analysis were performed to evaluate type II collagen synthesis. Proteoglycans deposition was detected by Alcian Blue
staining. A Field Emission In Lens Scanning Microscopy was used to look at the morphology of the immortalized cells at very high
magnification.
Results: Normal human articular chondrocytes were efficiently transfected leading to the establishment of an immortalized cell line as
confirmed by HPV-16 E7 mRNA and protein detection. These cells were able to re-express type II collagen both at mRNA and protein levels
under the two defined cultured conditions we used, still maintaining type I collagen expression. Collagen IX mRNA was present only in early
primary culture while collagen type X and aggrecan transcripts were always detected. Alcian Blue staining showed a proteoglycan-rich matrix
production. The ultrastructural analysis of the immortalized cells revealed that their morphology strictly resembled that of normal
chondrocytes.
Conclusions: The cell line that we obtained may be a useful tool for increasing our knowledge of the genetic and biochemical events involved
in the processes of cartilage growth and differentiation. Moreover, it appears to be a suitable model for pharmacological and toxicological
studies related to rheumatic diseases relevant to humans. © 2002 OsteoArthritis Research Society. Published by Elsevier Science Ltd.
All rights reserved.
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Hyaline articular cartilage is a highly specialized tissue
derived from mesenchyme during embryonic develop-
ment1. Chondrocytes, the only cell type of mature cartilage,
secrete and deposit around themselves a characteristic
extracellular matrix composed primarily of collagens,879proteoglycans and other non-collagenous proteins2. The
collagen architecture contributes to the tensile strength and
stiffness of cartilage while proteoglycans provide resistance
to compression. Type II collagen comprises about 90–95%
of total hyaline cartilage collagens and for that reason is
generally used as a differentiation marker for chondro-
cytes3. Smaller amounts of types V, VI, IX, XI are also
present4,5, together with type X collagen which has been
demonstrated to be restricted not only to the hypertrophic
chondrocytes within the zone of calcified cartilage6. The
predominant proteoglycan of articular cartilage is a hydro-
dynamically large, aggregating molecule termed aggrecan,
representing about 90% of the proteoglycans in the tissue7.
Chondrocytes can be easily isolated through enzymatic
removal of the matrix and then amplified in cell number by
serial subculture such as a monolayer8,9. The chondrocyte
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SOURCE OF CARTILAGE
Macroscopically normal human articular cartilage was
harvested aseptically within 6 h of death from the femoral
condyles of a 45-year-old male multiorgan donor who did
not have a known history of arthritis or related pathologies.CHONDROCYTE ISOLATION
Articular cartilage was minced into small pieces with a
scalpel and the slices were submitted to sequential diges-
tion: 30 min with 0.1% hyaluronidase (Sigma, St. Louis,
MO, U.S.A.), 1 h with 0.5% pronase (Sigma) and 45 min
with 0.2% collagenase (Sigma) at 37°C in Dulbecco’s
modified Eagle’s medium (DMEM) (GIBCO BRL, Grand
Island, NY, U.S.A.) with 25 mM HEPES (Sigma), 100
units/ml penicillin (Biological Industries, Israel), 100 g/ml
streptomycin (Biological Industries), 50 g/ml gentamicin
(Flow Laboratories, Biaggio, Switzerland). The isolated
chondrocytes were filtered through 100 m and 70 m
nylon meshes, washed and centrifuged. The pellet was
resuspended in DMEM supplemented with 20% fetal calf
serum (FCS) and then seeded at high density (2×105
cells/cm2) in flasks (Costar®, Cambridge, MA, U.S.A.), at
37°C in a humidified atmosphere of 5% CO2.PLASMID
The p16HHMo plasmid, a generous gift from Dr John T.
Schiller (Laboratory of Cellular Oncology, National Cancer
Institute NIH Bethesda, MD 20892), contains subgenomic
HPV-16 fragments cloned in pML2: the E6 and E7 genes as
intact open reading frames (ORFs) and a small part of the
E1 ORF, under the promotional control of the Moloney long
terminal repeats (MoLTR)23. Plasmid purification was
obtained using a plasmid-DNA isolation kit (Quiagen
GmbH, Hilden, Germany) according to the manufacturer’s
instructions.CATIONIC LIPOSOME-MEDIATED TRANSFECTION (LIPOFECTION)
Chondrocytes were transfected in early primary
culture at passage 1 (P=1), using the DOTAP Liposomalculture system represents a model for cartilage metabolism
investigation, which is essential for identifying the pathways
of both normal development and pathological degeneration
and inflammation of the tissue.
However, most studies using the monolayer culture
method have been seriously hindered. This was due mainly
to the cultured chondrocytes limited life span and to the
rapid modulation of their collagen phenotype that occurs
following the first subculture and that results principally in a
decrease in the synthesis of type II collagen and aggrecan
and in the up-regulation of type I collagen expressed in
prechondrogenic mesenchymal cells10.
Several attempts at stabilizing the chondrocyte pheno-
type in culture have been reported, for example, high
densities culture11, suspension culture on or within agar-
ose12, three-dimensional culture system in alginate
beads13, serum free defined medium14 and the use of
bioresorbable polymer carriers for the engineering of carti-
lage tissue implants15.
One more interesting approach is the generation of
cell lines displaying both infinite proliferation capacity and
stable phenotype. To date an immortalized chondrocyte
line seems to be the ideal model system for cartilage
research since it represents a permanent and abundant
source of cells expressing differentiated characteristics.
Until now, several immortalized chondrocyte lines of animal
or human origin have been successfully developed through
viral infection or transfection with selected single or multiple
oncogenes16–22, but the conservation of all differentiated
cell functions and their modulation has been often prob-
lematic. Moreover, in the case of the use of material of
human origin, a series of problems is encountered due to
the difficulty related to the availability of this material and
to ethical problems.
Goldring et al.21 established and characterized two
stable cell lines (C-20/A4 and T/C-28) by transfection of
primary cultures of human juvenile costal chondrocytes
with two different vectors both containing DNA encod-
ing simian virus 40 large T antigen (SV40-TAg). The
immortalized chondrocytes were able to express mRNAs
encoding the cartilage specific type II, IX and XI colla-
gens and proteoglycans in an insulin-containing serum
substitute21.
Recently, to overcome potential problems associated
with continuous expression of SV40-Tag, Robbins et al.22
immortalized primary human articular chondrocytes with a
retrovirus expressing a temperature-sensitive mutant of
SV40-large T antigen (tsTAg). The established tsT/AC62
cell line expressed, at the permissive temperature, the
differentiated type II collagen-producing phenotype when
maintained in monolayer culture at high density or in
alginate culture in serum-containing medium22. Despite the
previous study, they used, as target cells for immortaliz-
ation, articular chondrocytes isolated from human knee
cartilage after surgery for joint replacement for osteo-
arthritis due to injury, since articular cartilage represents
the primary joint tissue involved in arthritic diseases22.
The use of normal human articular cartilage obviously
could be more advantageous compared to osteoarthritic or
trauma-damaged cartilage, since in the latter cases some
inflammatory and/or degenerative events could alter the
physiologic characteristics of the original tissue.
In order to obtain a model system for both fundamental
research and clinical approach in the orthopaedic field, we
sought to develop a stable line of immortalized chondro-
cytes isolated from human adult articular healthy cartilage.
To achieve this, we stably transfected the cells in primaryculture with a plasmid containing two human papilloma
virus type 16 (HPV16) early function genes23, using the
highly efficient cationic liposome-mediated (lipofection) pro-
cedure24. These DNA viral oncogenes have been already
demonstrated to immortalize human keratinocytes and
human embryonic and myocardial fibroblasts by the inacti-
vation of host proteins involved in cell cycle control23,25,26.
Since the dedifferentiated phenotype obtained in
chondrocytes by serial subculture is reversible12,13, we
investigated the ability of the immortalized chondrocytes to
re-express their differentiated functions in two culture con-
ditions that have been described to re-induce differentiated
characteristics: culturing in a serum-free defined medium
supplemented with an insulin-containing serum21 substitute
termed Nutridoma-SP and seeding on a hyaluronan-based
non-woven structured biomaterial referred as to
HYAFF®11.
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cals, Indianapolis, IN, U.S.A.). The day before transfection,
cells were subcultured according to standard protocol and
plated in flasks at a density yielding approximately 60–80%
confluency at the time of the transfection. The DOTAP/
plasmid transfection mixture was prepared using polysty-
rene tubes with a ratio of 1 g of DNA per 7 l DOTAP. At
the time of transfection, culture medium was removed and
chondrocytes were incubated with medium without serum
containing the transfection mixture for 3 h at 37°C in a
humidified atmosphere of 5% CO2. The medium was then
replaced with fresh DMEM containing 20% FCS.
We tested three different plasmid concentrations: 5 g,
10 g and 15 g per flask, using chondrocytes from the
same multiorgan donor as target cells for all transfection
experiments. Non-transfected cells were used as a com-
parison control. Transfected and non-transfected chondro-
cytes were fed twice weekly with DMEM containing 20%
FCS. At confluency, which usually occurred after 7–10
days, they were passaged at a split ratio of 1:2.
The experiments with non-trasfected cells (control) were
performed at P=0 and/or P=1 for RT-PCR, immunohisto-
chemical, histochemical, Western blotting and ultrastruc-
tural analyses. At these early passages the cells are still
differentiated expressing the cartilage-specific molecules.
The experiments with transfected cells in monolayer culture
were performed after >40 passages from the transfec-
tion for RT-PCR, immunohistochemical, histochemical,
Western blotting and ultrastructural analyses. A further
period of culture of 14 days with 1% Nutridoma-SP and 30
days on HYAFF®11 scaffold was needed to permit the
re-expression of the naive phenotype. These two different
time culture periods were chosen on the basis of previous
experiments performed using normal human chondrocytes.SERUM-FREE DEFINED MEDIUM CONDITION CULTURES
Confluent immortalized chondrocytes were trypsinized at
P=42 (∼1 year and 1 month from the transfection) plated in
DMEM with 10% FCS and incubated at 37°C for 1 day. The
monolayer was rinsed with Dulbecco’s Ca2+- and Mg2+
free phosohate-buffered saline (PBS) and incubated with
culture medium containing 1% Nutridoma-SP (Boehringer
Indianapolis). Medium was changed twice a week and the
cells were splitted one time. After 14 days cells were
harvested and pellets processed for RT-PCR, immuno-
histochemical, histochemical and Western blotting
analyses.SEEDING ON BIOMATERIAL
The biomaterial used as a scaffold for three-dimensional
cell growth was a hyaluronan-based biopolymer,
HYAFF®11, obtained from F.A.B. S.r.l. (FIDIA Advanced
Biopolymers, Abano Terme, Italy), which has been shown
to be a suitable support that allows chondrocytes to
produce hyaline cartilage-specific matrix molecules27.
Immortalized chondrocytes cultured under conventional
monolayer culture were trypsinized at P=42 (∼1 year and
1 month from the transfection) and seeded onto 1×1 cm
HYAFF®11 non-woven meshes at a density of 1×106 in
150 l of culture medium in Petri dishes (Becton Dickinson,
Plymouth, U.K.). The cells were allowed to adhere for 8 h at
37°C and then 2 ml of medium was added. 50 g/ml
ascorbic acid was added daily only to the cultures that
underwent to the histological staining.The medium was changed twice a week. After 30 days
the scaffolds were collected and processed for RT-PCR,
immunohistochemical, histochemical and ultrastructural
analyses.RNA EXTRACTION AND REVERSE TRANSCRIPTASE PCR
Total RNA was extracted using RNAzol B reagent
(Biotecx Laboratories, Houston, TX, U.S.A.). 1×106 non-
transfected (P=0) and transfected chondrocytes (P=42)
cultured on a monolayer with DMEM supplemented with
FCS and in DMEM containing 1% Nutridoma-SP for 14
days were trypsinized, pelleted and lysed in 0.5 ml of
RNAzol B reagent. HYAFF®11 scaffolds with seeded trans-
fected chondrocytes were collected after 30 days, placed in
microcon 100 filtration devices and centrifuged at 1500×g
for 5 min in order to remove the liquid medium. Cells were
lysed directly in the culture scaffold by addition of 0.5 ml of
RNAzol B reagent. Total RNA was subsequently isolated
according to the manufacturer’s instructions. Complemen-
tary DNA was synthesized from 1 g of total RNA per
sample using Murine Leukemia Virus (MuLV) reverse
transcriptase (Perkin Elmer, Norwalk, CT, U.S.A.). The
reaction was made in a final volume of 20 l with 5 mM
MgCl2, 1 mM each deoxynucleotide, 2.5 M oligo-(dT),
1 U/ l RNase inhibitor and 2.5 U/ l MuLV reverse tran-
scriptase in 50 mM KCl, 10 mM Tris–HCl, pH 8.3. The
mixture was incubated at 22°C for 10 min, 42°C for 45 min,
heated to 99°C for 5 min and flash-cooled to 4°C. PCR
amplifications for type I, II, IX, X collagens (Col I-A1, Col
II-A1, Col IX-A1, Col X-A1), Aggrecan and HPV-16 E7 were
performed for 35 cycles of 30 s/95°C denaturation, 30 s
annealing and 30 s/72°C extension, using recombinant Taq
DNA Polimerase (Perkin Elmer). Specific primer pairs
and annealing temperatures are reported in Table I.
Samples were also amplified for the housekeeping gene
2-microglobulin used as internal quality standard. Positive
controls used in RT-PCR reactions were: non-transfected
chondrocyte (P=0) RNA for Col II-A1, Col IX-A1, Col X-A1
and aggrecan transcripts; human tonsillar stromal cells
(P=4) RNA for Col I-A1 transcript and purified p16HHMo
plasmid for HPV-16 E7 mRNA. In each reaction a negative
control (sample without template) was included.
PCR products were visualized on a 2% agarose gel
stained with ethidium bromide with a 100 bp DNA ladder
(Promega Corporation) as molecular weight marker.
Images were acquired under UV-light using the Kodak
Digital Science Electrophoresis Documentation and
Analysis System (EDAS) 120 (Kodak, Rochester, NY,
U.S.A.).IMMUNOFLUORESCENCE
Transfected chondrocytes were seeded directly onto
glass coverslips placed in six-well culture plates (Becton
Dickinson, Franklin Lakes, NJ, U.S.A.), at a density of
1×105 cells/coverslip. At confluence, the cells were
rinsed twice in PBS, fixed with 100% ethanol (The
Warner-Graham Company, Cockeisville, MD, U.S.A.) for
5 min and incubated with the anti-HPV-16-E7 mouse
monoclonal antibody, diluted 1:2 in PBS, (Zymed, San
Francisco, CA, U.S.A.) for 1 h at room temperature. Then,
after two washes in PBS, cells were incubated with the
secondary antibody: fluorescein (FITC)-conjugated goat
antimouse IgG (Jackson Immunoresearch, West Grove,
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ture. After three washes in PBS, coverslips were mounted
in glycerol 90% in PBS and observed with a Zeiss
Axiophot microscope equipped with a fluorescence lamp
(Oberkochen, Germany).IMMUNOHISTOCHEMISTRY
Immunohistochemical staining for type II collagen was
performed in non-transfected and in transfected chondro-
cytes at P=1 and P=42 respectively. The non-transfected
cells were evaluated in monolayer culture and the trans-
fected ones were evaluated in monolayer and once they
were grown into defined culture conditions. Chondrocytes
grown in monolayer were seeded in 8 Well Glass Slide
(Nalge Nunc International, Naperville, IL, U.S.A.) at a
density of 1.5×105 cells/well and after 72 h they were
rinsed twice in PBS, added with filtered FCS for 10 min and
then stored at –80°C. Chondrocytes grown onto HYAFF®11
scaffolds were embedded in OCT and snap-frozen in liquid
nitrogen. The specimens were then sectioned into 5 m
sections, air dried and stored at −80°C. At the moment of
the analysis all the slides were transferred at room tem-
perature, air dried for 15 min and fixed in acetone at 4°C for
10 min. Air dried fixed samples were rehydrated and incu-
bated at room temperature for 30 min with primary mono-
clonal antibody (MoAb) antihuman type II collagen
(Chemicon International, Temecula, CA, U.S.A.), that was
diluted 1:10 in 0.04 M pH 7.6 TBS containing 2% bovine
serum albumin (BSA) (Sigma). An enzymatic pre-treatment
with hyaluronidase 0.1% (Sigma) at 37°C for 5 min was
performed. Slides were washed three times with 0.04 M
pH 7.6 TBS and then incubated with goat antimouse
and antirabbit immunoglobulins labelled with destran
molecules-alkaline phosphatase conjugated (Envision,
Dako, Carpinteria, CA, U.S.A.) at room temperature for
30 min. After three washes with 0.04 M pH 7.6 TBS, the
reaction was developed using new fucsin kit (Kit New
Fucsin Substrate System, Dako, Carpinteria, CA, U.S.A.) in
the presence of 5 mM Levamisole (Sigma) to block endog-
enous alkaline phosphatase. Slides were counterstained
with hematoxylin, mounted in glycerol gel and stored at 4°C
for subsequent analysis. Negative controls were performedeither omitting the primary antibody or using an isotype-
matched control. Specific controls were performed using
irrelevant monoclonal antibodies.Table I
Primer sequences used for reverse transcriptase-polymerase chain reaction
RNA template Primer sequences Annealing
temperature
(°C)
Length
(base pairs)
References*
Type I collagen 5′-AAC GGC AAG GTG TTG TGC GAT G 61 296 28
3′-AGC TGG GGA GCA AAG TTT CCT C
Type II collagen 5′-AAC TGG CAA GCA AGG AGA CA 55 621 13
3′-AGT TTC AGG TCT CTG CAG GT
Type IX collagen 5′-GTG TTG CTG GTG AAA AGG GT 55 159 45
3′-GGG ATC CCA CTG GTC CTA AT
Type X collagen 5′-AGC CAG GGT TGC CAG GAC CA 59 387 13
3′-TTT TCC CAC TCC AGG AGG GC
Aggrecan 5′-ATG CCC AAG ACT ACC AGT GG 55 501 13
3′-TCC TGG AAG CTC TTC TCA GT
HPV-16 E7 5′-AAG CAG AAC CGG ACA GAG CC 57 398
3′-TTC CTG TGC AGT AAA CAA CGC
2-microglobulin 5′-CCT TGA GGC TAT CCA GCG TA 55 517
3′-TAT CTG AGC AGG TTG CTC CA
Note. *Primer sequences were obtained from published references where indicated, or designed using the
PRIMER3 analysis program.Fig. 1. Detection of HPV-16 E7 mRNA in immortalized normal
human adult articular chondrocytes with RT-PCR (ethidium
bromide stained agarose gel). L: DNA ladder (100 base
pairs); NTC: non-transfected chondrocytes; TC: transfected
chondrocytes; P: plasmid (p16HHMo).ALCIAN BLUE STAINING
Non-transfected and transfected chondrocytes were
plated at P=1 and P=42 respectively in plastic Lab-Tek 8
well chamber slides (Nalge Nunc International), at 1.5×105
cells/well, in DMEM and in DMEM containing 1%
Nutridoma-SP. Cells were grown for three days and 50 g/
ml fresh ascorbic acid was added every day. Chondrocytes
were then fixed in 10% neutral formaline 30 min at room
temperature and washed in distilled water. After fixation,
cells were stained in 1% Alcian Blue 8GX (Sigma, St. Louis,
MO, U.S.A.) in 3% glacial acetic acid (pH 2.5) 30 min at
room temperature, briefly washed in distilled water and
allowed to ‘blue’ 20 min in running tap water. Finally
chondrocytes were dehydrated through a series of alcohols
(70, 80, 90 and 100%), cleared in xylene and mounted in
Entellan (Merck, Darmstadt, Germany).
Alcian Blue staining was also performed onto HYAFF®11
engineered cryostat sections, which were firstly transferred
at room temperature, air dried for 15 min, fixed in 10%
neutral formaline 30 min at room temperature and
processed as described above.
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Western blotting for type II collagen was performed for
non-transfected and transfected chondrocytes using the
NuPAGE® (Novex high-performance pre-cast gels) Tris-
Acetate Electrophoresis System (Invitrogen, Carlsbad,
CA, U.S.A.), following the manufacturer’s instructions. Non-
transfected cells were evaluated in early primary culture
(P=1). Transfected chondrocytes were evaluated in
monolayer (P=42) in serum-free culture conditions
(Nutridoma-SP). Briefly, 50 000 adherent cells were
trypsinized and the pellets lysed and reduced with
NuPAGE® LDS Sample buffer (4×SDS) and NuPAGE®
Reducing Agent (0.5 M DTT) respectively, and then
heated for 10 min at 70°C. Whole cell lysates were
electrophoretically separated on Tris-Acetate buffered
3–8% polyacrylamide gel and blotted onto a nitrocellulose
membrane using a continuous buffer system (NuPAGE®
Transfer Buffer with 10% methanol). Protein standards
were used as molecular weight markers (SeeBlue Plus2
Pre-stained standard, Invitrogen). The blots were probed
with the same antihuman type II collagen MoAb used for
immunohistochemistry diluted 1:200 (Chemicon), followed
by ECL detection (Amersham Pharmacia Biotech, U.K.)
with a horseradish peroxidase-conjugated secondary anti-
body, diluted 1:1000. After an exposure time of 30 s on
Hyperfilm-ECL, the image was acquired using the KodakElectrophoresis Documentation and Analysis System
(EDAS) 120.Fig. 2. HPV-16 E7 protein localization by immunofluorescence in immortalized normal human adult articular chondrocytes. A specific
monoclonal antibody anti E7 protein was used.FIELD EMISSION IN LENS SCANNING ELECTRON MICROSCOPY
(FEISEM)
Sterilized silicon wafer chips of 3×5 mm used as
FEISEM specimen holders were coiled up with a thin layer
of sterile HYAFF®11 and on each device 2×105 of non-
transfected and transfected chondrocytes (at P=1 and
P=42 respectively) were deposited. The samples were
then cultivated for 3 and 7 days in DMEM supplemented
with 20% FCS at 37°C and 5% CO2. At the end of the
growth periods, the specimens were fixed with 1% glutar-
aldehyde in 0.1 M phosphate buffer pH 7.2 for 45 min,
post-fixed in 1% osmium tetroxide in Veronal buffer for
30 min, dehydrated in an increasing ethanol series and
critical point dried (Critical point dryer CPD 030, Bal-Tec
AG, Lichtenstein). Before the FEISEM analysis, all the
samples were coated with a 1.5 nm thick platinum–Carbon
film (Pt 80%; C 20%) by means of a multievaporation
device Balzers MED 010 (Bal-Tec). The instrument used for
observation was the FEISEM Jeol JSM 890 (Jeol Ltd,
Tokyo, Japan) at 7 kV accelerating voltage and 1×10−11 A
probe current.
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Transfected chondrocytes were maintained in culture in
DMEM supplemented with 20% FCS at 37°C in a humidi-
fied atmosphere of 5% CO2 until the setting time for the
experiments. At confluency, which usually occurred after
7–10 days, they were passaged at a split ratio of 1:2.
Non-transfected cells, used as a comparison control for
all the experiments, naturally senesced after 38 culture
passages in the monolayer as previously reported28.
Chondrocytes transfected with 15 g of the p16HHMo
plasmid entered a crisis just after the transfection pro-
cedure and did not recover. Chondrocytes transfected with
10 g and 5 g of the p16HHMo plasmid overcame the
crisis and were propagated further in monolayer culture.
For about 20 passages the two cell populations were
morphologically indistinguishable and the reached cell
density joined at confluence was similar (35 000±
40 000/cm2). However, the p16HHMo 10 g-transfected
cells started decreasing their proliferation rate and stopped
dividing at P=35 (data not shown), while cultures trans-
fected with 5 g of the plasmid were able to escape
senescence and have been propagated for more than 50
passages so far. At present the p16HHMo 5 g-transfected
chondrocytes are still growing in culture. Given the length
of time these cells have been in culture and the number of
passages since the control cells senesced, it is reasonable
to think that they will continue to grow indefinitely.EXPRESSION OF HPV-16 E7 mRNA
In general, RT-PCR and Western blotting analysis on
both transformed cervical and oral epithelial cells demon-
strated that the mRNA level of HPV-16 E7 corresponded to
the E7 protein level, while it is difficult to correlate E6
mRNA with protein expression29. The reason is that only a
single form of HPV-16 E7 mRNA has been identified in
cervical carcinoma, while the E6 mRNA exists in three
different forms, with the ratios among them varying among
samples. Thus RT-PCR analysis of E7 mRNA is more
straightforward than analysis of E6 mRNA29. In our exper-
iments, HPV-16 E7 mRNA expression was detected in
the chondrocytes transfected with 5 g of the p16HHMo
plasmid, starting from few passages after transfection
(Fig. 1), but not in the ones transfected with 15 g and
10 g (data not shown).EXPRESSION OF HPV-16 E7 PROTEIN
The HPV-16 E7 protein was detected by indirect
immunofluorescence in the cytoplasm of the 5 g-
p16HHMo-transfected chondrocytes, starting from the early
passages (Fig. 2). In chondrocytes transfected with 15 and
10 g no fluorescence was observed as for non-transfected
cells.Fig. 3. RT-PCR analysis of extra-cellular matrix protein mRNAs
expressed by HPV-16-immortalized normal human adult articular
chondrocytes (ethidium bromide stained agarose gel). L: DNA
ladder (100 base pairs); N: negative control (sample without
template); P=0: freshly isolated non-transfected chondrocytes;
M: monolayer culture of transfected chondrocytes at P=42;
N: Nutridoma-SP culture of transfected chondrocytes at P=42;
H: hyaluronan-based biomaterial (HYAFF®11) culture of
transfected chondrocytes at P=42.RE-EXPRESSION OF DIFFERENTIATED FUNCTIONS
Freshly isolated articular chondrocytes have been
shown to produce a matrix of collagens and proteoglycans
that is characteristic of cartilage. Our RT-PCR analyses
confirmed that, at the time of isolation (P=0), the normal
human adult articular chondrocytes that we used for ourexperiments were fully differentiated, expressing Col II-A1,
Col IX-A1, Col X-A1 and aggrecan mRNAs, but not Col I-A1
mRNA (Fig. 3). The cells kept the above-mentioned differ-
entiated characteristics just for the very first culture
passages from isolation (i.e. at the time of the transfection).
Starting from the 5th–6th subculture, transfected chondro-
cytes drastically switched from Col II-A1 to Col I-A1
mRNA expression, as expected in dedifferentiated cells10.
The cartilage-specific messengers for Col X-A1 and
aggrecan were still observed, while Col IX-A1 mRNA was
not detectable anymore (Fig. 3).
The stable proliferating chondrocyte line re-expressed
(at P=42) Col II-A1 mRNA under the two defined culture
conditions that we tested i.e. serum-free defined medium
containing 1% Nutridoma-SP and HYAFF®11 cultures,
despite retaining expression of Col I-A1 mRNA. The
cartilage-specific Col X-A1 and aggrecan mRNAs, but not
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conditions (Fig. 3).IMMUNOHISTOCHEMISTRY
The re-acquisition of the chondrocyte phenotype was
confirmed by the presence of type II collagen positive cells
in the two defined culture conditions studied [Fig. 4(a), (b)]
indicating the occurrence of a re-differentiation process.
Figure 4(c) represents fully differentiated chondrocytes in
an early culture passage: the totality of the cells show a
positive staining. The transfected chondrocytes further
propagated in monolayer (P=42) showed very low posi-
tivity for the protein, indicating a state of phenotipic
dedifferentiation [Fig. 4(d)].ALCIAN BLUE STAINING
Sulfated proteoglycans in the extra-cellular matrix,
detected by selective staining with Alcian Blue, can be one
of the markers of differentiated chondrocyte function30.
Transfected chondrocytes at P=42 grown in DMEM with
1% Nutridoma-SP were observed to deposit a
proteoglycan-rich matrix after 72 h of culture [Fig. 5(a)].
The same cells grown onto HYAFF®11 scaffold for a month
were able to synthesize an Alcian Blue-stainable extra-
cellular matrix [Fig. 5(b)]. As controls, Fig. 5(c) showsstrongly positive stainable material in the pericellular
regions of the non-transfected chondrocytes in early
primary culture (P=1), while Fig. 5(d) represents the
weakly stainable transfected cells in late monolayer culture
passages.WESTERN BLOTTING ANALYSIS
Western blotting analysis confirmed that transfected
chondrocytes cultured in serum-free defined conditions
synthesize type II collagen compared to the non-
transfected cells in primary culture (Fig. 6), further demon-
strating the re-acquisition of the differentiated phenotype by
this cell line.Fig. 4. Collagen II immunostaining of the immortalized cells at P=42 grown in serum-free medium (Nutridoma-SP) (a) and seeded on
HYAFF®11 (b) (the HYAFF®11 fibers are indicated with arrows). As controls are reported the non-transfected chondrocytes in the first culture
passage from isolation (c) and the transfected cells further propagated in monolayer (P=42) (d). Collagen II was developed using new fucsin
(red color is positive stain).MORPHOLOGICAL CHARACTERIZATION
The ultrastructural analysis performed by FEISEM
revealed a precocious tendency of the cell to adhere to the
HYAFF®11. In fact, after 3 days in several foci the wires of
the substratus were covered in cells. Mainly, they appear
flattened and tightly adherent to the HYAFF®11, even
characterized by a smooth surface and a tight overlapping.
Nevertheless, few elements were more globular and less
adherent to the substratus, with a surface covered in
heterogeneous microvilli and a border rich in spoke-like
886 B. Grigolo et al.: HPV-16 E6/E7 immortalized chondrocytesplasmalemmal evaginations [Fig. 7(a)]. At higher magnifi-
cations, the surface of the more globular cells appeared to
be covered in a filamentous secretion where a regular
period can be detected on the fibers [Fig. 7(b)]. After 7 days
of growing, almost all the globular cells appeared to be
replaced by flattened and adherent elements. Generally,
we didn’t observe in transfected chondrocytes relevant
morphological differences compared to the non-transfected
ones [Fig. 7(c)].Fig. 5. Alcian Blue staining of immortalized human chondrocytes grown in DMEM with 1% Nutridoma-SP (a) and onto HYAFF®11 scaffold
(b) (the HYAFF®11 fibers are indicated with arrows). As controls are reported the non-transfected chondrocytes in the first culture passage
from isolation (c) and the transfected cells further propagated in monolayer (P=42) (d). Alcian Blue-stainable material (referred to the
presence of proteoglycans) is evident in the pericellular regions of most of the cells in the cultures.Fig. 6. SDS-polyacrylamide (3–8% w/v) gel electrophoresis of
collagen type II. NTC: non-transfected chondrocytes at P=1; TC:
transfected chondrocytes at P=42 in Nutridoma-SP culture. An
antihuman type II collagen monoclonal antibody diluted 1:200 was
used. The arrows indicate the protein standard weight markers.Discussion
Articular chondrocytes in primary cultures are generally
considered to be a well-differentiated cell population: they
synthesize high levels of cartilage proteoglycans and type II
collagen2. When serially cultured in monolayers they cease
to synthesize cartilage-specific macromolecules, replacing
them with molecules normally expressed by mesenchymal
cells, like type I collagen3,10,13.
In this study, adult normal human articular chondrocytes
were transfected in primary culture with a plasmid contain-
ing the two HPV-16 early function genes E6 and E7
(p16HHMo). This led to immortalization of these cells and
to an apparently irreversible suppression of their type II
collagen-differentiated phenotype, stable expression of
type I collagen and synthesis of an extracellular matrix as
shown by the Alcian Blue staining.
HPV-16 E6 and E7 expression is likely to be respon-
sible for this immortalization since no proliferation was
observed in non-transfected cells after they had reached
senescence. The E6 and E7 genes products are onco-
proteins, which exert their biological effects mainly by
binding respectively with the products of p53 and retino-
blastoma genes and thus inactivating these tumor suppres-
sor genes31. This causes deregulation of the cell cycle with
loss of control on crucial events, such as DNA replication,
DNA repair and apoptosis31.
Osteoarthritis and Cartilage Vol. 10, No. 11 887Fig. 7. Field Emission in Lens Scanning Electron Microscopy
(FEISEM) images of immortalized normal human adult chondro-
cytes after 3 days from the seeding on the biomaterial HYAFF®11
(hyaluronan-based non-woven structured biomaterial). (a) The
wires of HYAFF®11 are detectable covered by adherent and
smooth cells. Rare non-adherent cells are also evident and char-
acterized by more irregular surface and shape (origin. magn.:
900×). (b) Detail of the same field. Irregularly sized microvilli
decorate the surface of the non-adherent cells. A characteristic
regularly banded filamentous secretion is also evident (orig.
magn.: 20 000×). (c) Non-transfected chondrocytes seeded on the
biomaterial HYAFF®11 after three days of culture used as control
(orig. magn.: 1200×).Oncogenic HPV-16 is strongly associated with cervical
cancer and its precursor, cervical intraepithelial neo-
plasia32. It has been shown that the HPV-16 genome has in
vitro activity in its natural host cells: when transfected onto
normal human foreskin keratinocytes or human cervical
epithelial cells it was able to indefinitely extend cell
proliferative capacity33. Further analyses were undertaken
in order to define the early HPV-16 genes that directly
participate in the in vitro transformation process. Different
studies using respectively primary human keratinocytes34,
primary human embryonic fibroblasts (WI38)25 and human
bronchial epithelial cells35, as target cells for transfection,
demonstrated that both full-length E6 and E7 genes are
required for the induction of immortalization. In fact, muta-
tions in either the E6 or E7 ORF completely abrogated
transformation of these cells. Mutations in E1, E2 and
E2–E4 ORFs, on the other hand, had no effect36. Hawley-
Nelson et al. demonstrated that transfection with the
p16HHMo plasmid, in which E6 and E7 were the only intact
ORFs, induced an indefinite lifespan in human genital
keratinocytes, with an efficiency similar to that of the entire
early region of the viral DNA23. Moreover, it has been
demonstrated that human smooth muscle, bone marrow
and myocardial immortalized cells expressing HPV-16
E6 and E7 oncogenes display a quite well preserved
phenotype26,37,38.
In several reports, the SV40T-Ag and the myc oncogene
have been transfected into chondrocyte cultures and
immortalized chondrocyte cell lines have been obtained,
with varying results regarding the maintenance of the
differentiated phenotype16–22. Although cartilage-specific
proteoglycan synthesis has been demonstrated in several
immortalized chondrocyte lines, the expression of type II
collagen seems to be particularly difficult to maintain. While
several authors reported either the complete loss or a
marked decrease in type II collagen in immortalized
chondrocytes17,19,20, some cell lines of v-myc- or T-Ag-
immortalized chondrocytes maintained the expression of
this marker16,18,21,22. Given the chondrocyte phenotype in
vitro lability and the dissociation of proliferative and pheno-
typic stabilities found in some immortalized chondrocyte
systems, we investigated which kind of molecules the
articular normal human E6/E7-immortalized chondrocyte
line that we obtained was able to express. Like normal
articular chondrocytes grown in conventional culture condi-
tions, our immortalized chondrocytes expanded in mono-
layer did not express type II and IX collagen mRNAs while
retaining the expression of aggrecan and type X collagen
already evidentiated at the early culture passages. More-
over, they started to express type I collagen, a classically
described marker of dedifferentiated chondrocytes. This
dedifferentiation process was also demonstrated by
immunohistochemical and histochemical analyses that
showed the lack of production of collagene type II and a
weak synthesis of proteoglycans. When we evaluated our
immortalized cells in two culture conditions that have been
shown to successfully induce re-expression of chondrocyte
original characteristics (culturing in a serum-free defined
medium and seeding on a three-dimensional support) we
detected the re-expression of the messenger for type II
collagen, the main differentiation marker for chondrocytes,
and the maintenance of the expression of collagen type X
which is probably a characteristic molecule of this cell line.
These data were also confirmed at protein level by the
detection of collagen type II protein by immunohistochem-
istry and Western blotting analysis and by the detection of
888 B. Grigolo et al.: HPV-16 E6/E7 immortalized chondrocytesa proteoglycans active synthesis revealed by Alcian blue
staining.
Most animal and human cell lines have been established
in serum-supplemented medium39. However, a number of
them required hormonally defined serum-free medium cul-
ture conditions in order to allow cell survival, growth and/or
maintenance or re-expression of differentiated charac-
teristics. The stable proliferating lines of immortalized
human chondrocytes (C-20/A4 and T/C-28) established by
Goldring et al. had an optimal expression of type II collagen
mRNA only after one to several days of culture in serum-
free defined medium supplemented with 1% Nutridoma-SP,
an insulin-containing serum substitute21 and 50 g/ml
ascorbic acid (which stimulates the neosynthesis of colla-
gen molecules)40. Insulin may serve as a substitute for
insulin-like growth factor-I (IGF-I), a major stimulator of
matrix synthesis in cartilage41. FCS replacement with 1%
Nutridoma-SP was permissive for type II collagen mRNA
re-expression and, together with ascorbic acid, for protein
production by our immortalized chondrocytes. Otherwise,
type I collagen mRNA was still expressed even if it was not
detected in the C-20/A4 and T/C-28 lines, under these
same culture conditions21.
The use of polymeric bioresorbable scaffolds as devices
for chondrocyte growth and differentiation in order to
produce a three-dimensional cartilage tissue is well
documented15,42–44. Our previous experiments demon-
strated that human articular dedifferentiated chondrocytes
grown onto HYAFF®11 non-woven meshes re-express type
II collagen27. When we investigated the re-differentiation
capability of the HPV-16-immortalized chondrocytes in the
same culture conditions, we detected type II collagen
mRNA expression and protein production after 30 days of
culture. However, type I collagen mRNA was still present.
Thus, as observed for dedifferentiated chondrocytes,
HYAFF®11 represents a suitable cell carrier that enhances
the HPV-16-immortalized chondrocytes to revert to their
original function of producing type II collagen. Moreover,
the ultrastructural analysis reveals how similar the behavior
of this cell line can be compared to the non-immortalized
chondrocytes. In fact, both the time necessary for the full
adhesion to the HYAFF®11 and the three-dimensional
pattern of the cells after the adhesion appears the same.
Also the typical cell orientation in the secretion of collagen
microfibrills appears strictly related to the adhesion in this
model as well as in the non-immortalized cells27.
In summary, HPV-16 early genes were able to immortal-
ize normal human adult articular chondrocytes, allowing
the establishment of a new cell line expressing specific
cartilage molecules, even if further studies are needed to
better characterize it.
This line could be a useful model system for studying the
metabolism of chondrocyte cells and their responsiveness
to treatments which are known to modulate their pheno-
type. These data will shed important light on our under-
standing of the biology of these cells and may have
therapeutic implications in combating some of the most
important rheumatic diseases.Acknowledgments
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